Learn more about emerging clinical data guidelines and regulatory approvals for patients with IgA nephropathy in this interactive text module The activity features patient perspective audio clips a pathogenesis animation and accompanying downloadable slides to provide an informed approach to optimizing patient outcomes in IgAN
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/nephrology/management-of-igan/19793-41788
- Start Date: 2024-07-01 05:00:00
- End Date: 2024-07-01 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours - Commercial Support: Source: Novartis Corporation Pharmaceuticals - Amount: 159000.0 - Is Kind Support: False Source: Otsuka America Pharmaceutical, Inc. - Amount: 159000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest